Best Practices

Mighty mitochondria: Cell powerhouses harnessed for healing

Infusion of the tiny, sausage-shaped structures helps to rejuvenate tissues deprived of blood. Researchers hope the technique can treat a variety of damaged organs. James McCully was in the lab extracting tiny structures called mitochondria from cells when researchers on his team rushed in. They’d been operating on a pig heart and couldn’t get it pumping normally again. McCully studies heart...

read more

Science Literacy Gone Viral

TikTok and other social media are inundating youth with misinformation. But educators find the platform can also be a powerful tool, teaching students to parse truth from fiction. The goal of my medical writing class at the University of Delaware is to teach STEM students how to translate nerd jargon to the general public. But more and more, I find myself guiding them through the reverse...

read more

Doulas, Once a Luxury, Are Increasingly Covered by Medicaid — Even in GOP States

As a postpartum doula, Dawn Oliver does her best work in the middle of the night. During a typical shift, she shows up at her clients’ home at 10 p.m. She answers questions they may have about basic infant care and keeps an eye out for signs of postpartum depression. After bedtime, she may feed the baby a bottle or wake the mother to breastfeed. She soothes the infant back to sleep. Sometimes,...

read more

Navigating Shared Savings Issues in ACO Reach and ACO MSSP

If you’re a healthcare provider working under DCE (ACO Reach or ACO MSSP models), you’ve likely experienced the unique challenges of shared savings agreements. These programs can be a fantastic tool for improving care coordination and reducing costs, but as an attorney who has worked extensively in this field, I’ve seen firsthand how complex and frustrating these agreements can become. One of...

read more

Why Do Americans Pay More for Prescription Drugs?

ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox. In the U.S., the price of Revlimid, a brand-name cancer drug, has been increasing for two decades. It now sells for nearly $1,000 a pill. In Europe, the price has been consistently lower — in some countries by two-thirds. I started reporting on...

read more

In the Name of Health: First Reactions to the MAHA Report

The first report from the Make America Healthy Again Commission is out, with a particular focus on children’s health. The relatively short report includes astonishing data on obesity, heart disease, diabetes, life expectancy, substance abuse, mental illness, and many other terribles. The report is a shock, a painful read, a five-alarm fire, and the charts alone are astonishing. It is embedded...

read more